<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Breast Cancer | Matthew A. Clarke</title>
    <link>https://mclarke1991.github.io/tag/breast-cancer/</link>
      <atom:link href="https://mclarke1991.github.io/tag/breast-cancer/index.xml" rel="self" type="application/rss+xml" />
    <description>Breast Cancer</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Tue, 07 Nov 2023 15:16:27 +0000</lastBuildDate>
    <image>
      <url>https://mclarke1991.github.io/media/icon_hu10226378635250344412.png</url>
      <title>Breast Cancer</title>
      <link>https://mclarke1991.github.io/tag/breast-cancer/</link>
    </image>
    
    <item>
      <title>DNA Damage Repair and Radiotherapy</title>
      <link>https://mclarke1991.github.io/project/radiotherapy/</link>
      <pubDate>Tue, 07 Nov 2023 15:16:27 +0000</pubDate>
      <guid>https://mclarke1991.github.io/project/radiotherapy/</guid>
      <description>&lt;p&gt;Cancers often emerge, in part, due to deficencies in DNA damage repair, making them vulnerable to DNA damaging treatments such as radiotherapy. While radiotherapy efficacy has been increasing, this is mainly due to better targeting of tumour anatomy, but targeted therapy offers the opportunity to radiosensitise tumour cells by targeting vulnerabilities in the tumour biology. We use computational modelling to find such vulnerabilities, and explore potential resistance mechanisms.&lt;/p&gt;
&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.749496/full#h9&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Elbana et al. &lt;em&gt;Front. Oncol&lt;/em&gt; 2021&lt;/a&gt;. &lt;a href=&#34;https://creativecommons.org/licenses/by/4.0/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;CC-BY 4.0&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Prediction of personalised therapies for triple-negative breast cancer using computational network modelling</title>
      <link>https://mclarke1991.github.io/talk/prediction-of-personalised-therapies-for-triple-negative-breast-cancer-using-computational-network-modelling/</link>
      <pubDate>Wed, 17 May 2023 15:50:15 +0100</pubDate>
      <guid>https://mclarke1991.github.io/talk/prediction-of-personalised-therapies-for-triple-negative-breast-cancer-using-computational-network-modelling/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Combination therapy</title>
      <link>https://mclarke1991.github.io/project/combination_therapy/</link>
      <pubDate>Wed, 08 Mar 2023 20:25:03 +0000</pubDate>
      <guid>https://mclarke1991.github.io/project/combination_therapy/</guid>
      <description>&lt;p&gt;Computatational modelling allows screening of thousands of combinations of drugs to find the most effective treatments. This allows for better protection against the emergence of resistance, as well as rapid drug repurposing e.g. to combat emerging diseases such as COVID-19.&lt;/p&gt;
&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.pnas.org/doi/full/10.1073/pnas.1903485116&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Kreuzaler &amp;amp; Clarke et al., &lt;em&gt;PNAS&lt;/em&gt; 2019&lt;/a&gt;. &lt;a href=&#34;https://creativecommons.org/licenses/by/4.0/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;CC-BY 4.0&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Predicting personalised therapies for triple-negative breast cancer using computational network modelling</title>
      <link>https://mclarke1991.github.io/talk/predicting-personalised-therapies-for-triple-negative-breast-cancer-using-computational-network-modelling/</link>
      <pubDate>Fri, 10 Feb 2023 15:30:00 +0000</pubDate>
      <guid>https://mclarke1991.github.io/talk/predicting-personalised-therapies-for-triple-negative-breast-cancer-using-computational-network-modelling/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling</title>
      <link>https://mclarke1991.github.io/publication/kreuzaler2019/</link>
      <pubDate>Tue, 29 Oct 2019 13:13:42 +0000</pubDate>
      <guid>https://mclarke1991.github.io/publication/kreuzaler2019/</guid>
      <description>&lt;p&gt;Image credit: Adapted from &lt;a href=&#34;https://www.pnas.org/doi/full/10.1073/pnas.1903485116&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Kreuzaler &amp;amp; Clarke et al., &lt;em&gt;PNAS&lt;/em&gt; 2019&lt;/a&gt;. &lt;a href=&#34;https://creativecommons.org/licenses/by/4.0/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;CC-BY 4.0&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
